X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Fulford India with ALEMBIC PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs ALEMBIC PHARMA - Comparison Results

FULFORD INDIA    Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FULFORD INDIA ALEMBIC PHARMA FULFORD INDIA/
ALEMBIC PHARMA
 
P/E (TTM) x 398.8 28.0 1,425.5% View Chart
P/BV x 6.2 6.4 97.4% View Chart
Dividend Yield % 0.1 0.7 11.5%  

Financials

 FULFORD INDIA   ALEMBIC PHARMA
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
ALEMBIC PHARMA
Mar-16
FULFORD INDIA/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs942792 119.0%   
Low Rs450443 101.6%   
Sales per share (Unadj.) Rs691.4167.0 413.9%  
Earnings per share (Unadj.) Rs11.538.2 30.0%  
Cash flow per share (Unadj.) Rs15.442.0 36.6%  
Dividends per share (Unadj.) Rs2.004.00 50.0%  
Dividend yield (eoy) %0.30.6 44.3%  
Book value per share (Unadj.) Rs380.084.9 447.6%  
Shares outstanding (eoy) m3.90188.52 2.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.03.7 27.2%   
Avg P/E ratio x60.716.2 375.4%  
P/CF ratio (eoy) x45.314.7 308.2%  
Price / Book Value ratio x1.87.3 25.2%  
Dividend payout %17.410.5 166.5%   
Avg Mkt Cap Rs m2,714116,383 2.3%   
No. of employees `0000.4NA-   
Total wages/salary Rs m5054,214 12.0%   
Avg. sales/employee Rs Th6,073.0NM-  
Avg. wages/employee Rs Th1,137.4NM-  
Avg. net profit/employee Rs Th100.7NM-  
INCOME DATA
Net Sales Rs m2,69631,487 8.6%  
Other income Rs m12555 227.6%   
Total revenues Rs m2,82231,542 8.9%   
Gross profit Rs m-4610,060 -0.5%  
Depreciation Rs m15722 2.1%   
Interest Rs m1037 25.8%   
Profit before tax Rs m549,356 0.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-2 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m102,160 0.4%   
Profit after tax Rs m457,194 0.6%  
Gross profit margin %-1.731.9 -5.4%  
Effective tax rate %17.723.1 76.6%   
Net profit margin %1.722.8 7.3%  
BALANCE SHEET DATA
Current assets Rs m1,73815,066 11.5%   
Current liabilities Rs m5457,674 7.1%   
Net working cap to sales %44.323.5 188.6%  
Current ratio x3.22.0 162.6%  
Inventory Days Days4867 72.4%  
Debtors Days Days441 10.6%  
Net fixed assets Rs m128,237 0.1%   
Share capital Rs m39377 10.3%   
"Free" reserves Rs m1,44315,416 9.4%   
Net worth Rs m1,48216,005 9.3%   
Long term debt Rs m00-   
Total assets Rs m2,07724,594 8.4%  
Interest coverage x6.7255.2 2.6%   
Debt to equity ratio x00-  
Sales to assets ratio x1.31.3 101.4%   
Return on assets %2.629.4 8.9%  
Return on equity %3.044.9 6.7%  
Return on capital %4.358.7 7.3%  
Exports to sales %055.7 0.0%   
Imports to sales %24.510.4 234.5%   
Exports (fob) Rs mNA17,551 0.0%   
Imports (cif) Rs m6593,283 20.1%   
Fx inflow Rs m1717,811 0.1%   
Fx outflow Rs m6735,318 12.7%   
Net fx Rs m-65612,493 -5.3%   
CASH FLOW
From Operations Rs m909,304 1.0%  
From Investments Rs m105-3,105 -3.4%  
From Financial Activity Rs m-14-1,959 0.7%  
Net Cashflow Rs m1814,240 4.3%  

Share Holding

Indian Promoters % 0.0 74.1 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 3.8 2.9 131.0%  
FIIs % 0.1 9.1 1.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.2 13.9 152.5%  
Shareholders   4,783 49,328 9.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FULFORD INDIA With:   ASTRAZENECA PHARMA  DR. DATSONS LABS  ELDER PHARMA  NOVARTIS  SUVEN LIFE  

Compare FULFORD INDIA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Surges 400 Points; HDFC Twins Up 3%(01:30 pm)

After opening the day in green, share markets in India have continued the momentum and are presently trading near all-time high levels.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

The ONLY Thing You Need to Know About Bitcoin(The 5 Minute Wrapup)

Jan 6, 2018

You either want it or you want to get as far away from it as possible - but Bitcoin is just the noise masking the REAL opportunity. Read about it here...

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FULFORD INDIA - FRESENIUS KABI ONCO. COMPARISON

COMPARE FULFORD INDIA WITH

MARKET STATS